| Schauer, Nicolas (Biocrates 201909– Co-CEO + CSO before Metabolomic Discoveries Managing Director + Founder) |
Managing Director |
Metabolon (Group) |
Germany |
| Schavan, Annette (BMBF 2006) |
n. a. |
Germany (govt) |
Germany |
| Scheefers, Hans (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Scheefers-Borchel, Ursula (ScheBo Biotech 201102 Executive Director) |
Board member, executive |
ScheBo Biotech (Group) |
Germany |
| Scheefhals, Guus (Crossbeta Biosciences 201303 CEO) |
Chief Executive Officer (CEO) |
Crossbeta Biosciences B.V. |
Netherlands |
| Scheek, Sigrid (Ascenion 200801 Technology Manager) |
IP Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
| Scheel, Andreas (Evotec 202004 EVP Head of Cell Therapy + PanCella 202004– Supervisory Board Member) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Scheer, Alexander (Erytech 201610– CSO before Pierre Fabre + Merck Serono + Serono) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Erytech (Group) |
France |
| Scheer, Nico (Cevec 201511– VP Business Development Glycoproteins before Taconic Biosciences/Artemis) |
Business Development Manager / Strategy Manager |
Danaher (Group) |
Germany |
| Scheffer, Petra (Bruker Corp 201701 Director of MarCom at Bruker Daltonics) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Scheffler, Matthias (Biocrates 201911 CBO + Head Marketing + Sales before Febit) |
Chief Business Officer (CBO) |
Biocrates (Group) |
Austria |
| Schefold, Christian (Dentons 201501– Counsel before Counsel at Daimler + Daimler Financial Services) |
Attorney / Lawyer |
Dentons (Group) |
Switzerland |
| Scheibner, Holger (IMI Consulting 200503) |
n. a. |
IMI Consulting GmbH |
Germany |
| Scheidegger, Alfred (Nextech Invest 201104 CEO + Founding Partner) |
Chief Executive Officer (CEO) |
Nextech (Group) |
Switzerland |
| Scheidle, Jörg (Immatics 200501– CFO before BrainLab) |
Chief Financial Officer (CFO) |
Immatics (Group) |
Germany |
| Scheiflinger, Friedrich (Fritz) (Evotec 202004 EVP Head Gene Therapy before Shire/Takeda 201707 Head Global Research) |
President/Director/Head Business Group/Unit/Division |
Evotec Gene Therapy (Orth, AT, Evotec GT) |
Austria |
| Scheinert, Peter (AmpTec GmbH 201201 Managing Director) |
Managing Director |
Merck (DE) (Group) |
Germany |
| Scheipers, Andreas (sense2care 201101 Managing Director) |
Managing Director |
sense2care GmbH |
Germany |
| Scheitza, Rüdiger (Bayer CropScience 200504) |
n. a. |
Bayer (Group) |
Germany |
| Schelhorn, Thomas (Hologic 201304 Hologic/Gen-Probe Senior Marketing Manager Europe HPV) |
Sales Manager / Marketing Manager |
Hologic (Group) |
Germany |
| Schell, Simone (Trelleborg 201704 Project Developm Engineer Life Sciences Europe at Trelleborg Sealing DE) |
Business Development Manager / Strategy Manager |
Trelleborg (Group) |
Germany |
| Scheller, Frieder W. |
n. a. |
University of Potsdam |
Germany |
| Scheller, Ulrich (BBB Management GmbH Campus Berlin-Buch 201104 Managing Director) |
Managing Director |
Campus Berlin-Buch GmbH |
Germany |
| Scheltema, Richard (Univ Utrecht 202008 at Heck lab) |
Researcher (university / research institute) |
University of Utrecht (Utrecht University) |
Netherlands |
| Schendel, Dolores J. (Medigene 202207– CSO + Head of RnD before CEO + CMO + Triant + HelmholtzZentrum München) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Medigene (Group) |
Germany |
| Schenk, Alexander (SeSaM-Biotech 200811– Managing Director + Co-Founder before Jacobs Univ) |
Managing Director |
SeSaM-Biotech GmbH |
Germany |
| Schenk, Dale B. (Prothena 2012–2016 CEO + Co-Founder before Élan DIED 9/16) |
Chief Executive Officer (CEO) |
Prothena (Group) |
Ireland, Republic of |
| Schenke-Layland, Katja (Univ Tübingen 201805 Prof + Managing Director of NMI) |
Managing Director |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Schenkel, Anke (Merck (DE) 201704– Head of Group Controlling & Risk Management joined 2010 before PWC) |
Controller (management) |
Merck (DE) (Group) |
Germany |
| Schenkendorf, René (Harz Univ 202109 Professor for Manufacturing/Industry 4.0 before TU Braunschweig) |
Professor |
Harz University of Applied Sciences Wernigerode |
Germany |
| Schepp, Jim (Diatron 201603 CEO) |
Chief Executive Officer (CEO) |
Stratec (Group) |
Hungary |
| Scher, Irwin (Biosynexus 200506– CEO before Merck KGaA) |
Chief Executive Officer (CEO) |
QVT Fund L.P. |
United States (USA) |
| Scherbel, Ulrich (AMSilk 202101– CEO joined as COO 202010 before Global Apparel Division of Freudenberg) |
Chief Executive Officer (CEO) |
AMSilk GmbH |
Germany |
| Scherer, Dieter (Novaliq GmbH 200904– CBO before Apis Pharma + SKyePharma CH + LTS Lohmann) |
Chief Business Officer (CBO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
| Scherer, Jörg (EURICE 201201 Managing Director) |
Managing Director |
European Research and Project Office GmbH (EURICE) |
Germany |
| Scherer, Mirko (MPM Capital 201207– Managing Director Munich + KI Capital before GPC Biotech CFO) |
Managing Director |
MPM Capital (Group) |
Germany |
| Scherer, Stefan (Alicona 201811 Managing Director) |
Managing Director |
Bruker (Group) |
Austria |
| Scherer, Stefan (Biocartis 201303– CMO before Roche/Genentech + Grünenthal) |
Chief Medical Officer (CMO) |
Biocartis (Group) |
Switzerland |
| Scherhag, Rudi (Neuway Pharma 201508– Managing Director before ImClone Systems + Heidelberg Pharma + Roche Mannheim) |
Managing Director |
Neuway Pharma GmbH |
Germany |
| Schermeier, Olaf (Fresenius 201911 CEO for Global RnD of Fresenius Medical Care) |
Chief Executive Officer (CEO) |
Fresenius (Group) |
Germany |
| Scherrer, Frank (Wenger & Vieli 200809 Zurich) |
n. a. |
Wenger & Vieli Attorneys at Law (Zurich) |
Switzerland |
| Scherz, Michael, Ph.D. (Metys Pharmaceuticals 201304– CEO + Co-Founder before Actelion 2000–2012 + P&G Pharma) |
Chief Executive Officer (CEO) |
Metys Pharmaceuticals AG |
Switzerland |
| Schetter, Christian (Rentschler 202109– CSO before Arix Bioscience + Rigontec + Fresenius Biotech + Coley GmbH) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Arix Bioscience (Group) |
United Kingdom (GB) |
| Scheuble, Bernhard (Merck KGaA –200511) |
n. a. |
Merck (DE) (Group) |
Germany |
| Scheuch, Gerhard (Activaero 201105 CEO + Founder) |
Chief Executive Officer (CEO) |
Vectura (Group) |
Germany |
| Scheule, Albertus M. (Univ Hospital Tübingen 201506 Prof + CaveoMed GmbH 201404– Managing Director + Founder) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Schick, Georg (201201 VP Industrial Sales + Marketing at Bruker Elemental division) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
| Schier, Eva (AC Immune 201605 Corporate Communciations Manager) |
public relations / investor relations |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Schier, Robert (Zürcher Kantonalbank 201909 Investment Director PE/V Health-Tech at Swisscanto Invest) |
Investment Manager |
Zürcher Kantonalbank (ZKB) |
Switzerland |
| Schierenbeck, Andreas (HH2E 202206 Board Member + Co-Founder) |
Board member, executive |
HH2E (Group) |
Germany |
| Schiermeier, Andrew (Intellia Therapeutics 202106 EVP + COO before Merck (DE) 201504 Head Global Oncology) |
Chief Operating Officer (COO) |
Intellia Therapeutics Inc. (Nasdaq: NTLA) |
United States (USA) |
| Schiersing, Monique (Roche 201510 Roche Venture Fund) |
Investment Manager |
Roche (Group) |
Switzerland |
| Schiess, Ralph (Proteomedix 202001 CSO + Co-Founder before CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Proteomedix AG |
Switzerland |
| Schiewe, Hajo (Proteros 200708 EVP Business Development) |
Business Development Manager / Strategy Manager |
Proteros (Group) |
Germany |
| Schiff, Andrew (Aisling Capital 202009) |
Investment Manager |
Aisling Capital Management |
United States (USA) |
| Schifrin, Alexander (Metabolomic Discoveries 201604 Business Development Manager) |
Business Development Manager / Strategy Manager |
Metabolon (Group) |
Germany |
| Schikan, Hans (Prosensa 200910 CEO) |
Chief Executive Officer (CEO) |
BioMarin (Group) |
Netherlands |
| Schild, Hansjörg (Univ Mainz 201312 Prof + Director of Institute for Immunology at Univ Medical Center) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
| Schill Schulze, Natascha (Neurimmune 201811– VP Project + Alliance Management before 22 years at Biogen) |
Business Development Manager / Strategy Manager |
Neurimmune AG |
Switzerland |
| Schiller, Madlen (Biosaxony 201607 Project Manager at Biosaxony e.V.) |
Cluster Manager |
Biosaxony Management GmbH |
Germany |
| Schillert, Alfred (Provendis 201501 Managing Director) |
Managing Director |
Provendis GmbH (Patentagentur NRW) |
Germany |
| Schilling, Guido (Axis-Shield 2008– Managing Director of newly acquired Axis-Shield AG before Nycomed AG Marketing Man) |
Managing Director |
Alere (Group) |
Switzerland |
| Schilz, Andrea (Ci3 Cluster 201307 Managing Director of Ci3 Management UG) |
Cluster Manager |
Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.) |
Germany |
| Schimkat, Dirk (Neurimmune 201104 CFO before Beiersdorf before Univ Basel) |
Chief Financial Officer (CFO) |
Neurimmune AG |
Switzerland |
| Schimmer, Ove (Sequid GmbH 2007– Managing Director + co-founder) |
Managing Director |
Sequid GmbH |
Germany |
| Schindler, Marcus (Novo Nordisk 201801– before AstraZeneca) |
President/Director/Head Business Group/Unit/Division |
Novo Group (Group) |
Denmark |
| Schindler, Stephan (Bachem 201203 CFO) |
Chief Financial Officer (CFO) |
Bachem (Group) |
Switzerland |
| Schinecker, Thomas (Roche 202208 CEO of Roche Diagnostics formerly 201110 President of 454 Life Sciences) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Schipper, Heiko (Bayer 201907 President of Consumer Health) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
United States (USA) |
| Schirmers, Bernhard (SHS Gesellschaft für Beteiligungsmanagement 201110 Partner + Managing Director) |
Managing Director |
SHS Capital (Group) |
Germany |
| Schirrmann, Thomas (Yumab GmbH 201907 Managing Director + Covat Therapeutics 202005– Managing Director) |
Managing Director |
Yumab GmbH |
Germany |
| Schirrow, Renate (CENiMED 200508 Managing Director) |
Managing Director |
CENiMED GmbH Center for Indivdualized Medicine |
Germany |
| Schlack, Stefan (Sartorius 201210– SVP Marketing at Sartorius Stedim Biotech at Sartorius since 1996) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
| Schladot, Johann-Diedrich |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Schlange, Thomas (Bayer 201504 Senior Scientist Global Biomarker Research at Bayer HealthCare) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Schlapbach, Jakob (Delenex 201012– CFO before 10y+ Cytos Biotechnology CFO before Ascom CFO) |
Chief Financial Officer (CFO) |
Athenex (Group) |
Switzerland |
| Schleef, Martin (PlasmidFactory 201106 Managing Director) |
Managing Director |
PlasmidFactory GmbH & Co. KG |
Germany |
| Schleis, Ulrich (Thermo Electron 200512) |
n. a. |
Thermo Fisher (Group) |
Germany |
| Schlenga, Klaus (Bruker 201006 CTO at BEST) |
Chief Technology/Technical Officer (CTO) |
Bruker (Group) |
United States (USA) |
| Schlenk, Michael (Curasan 201410– Executive Board Director before Centogene + ProBioGen) |
Board member, executive |
Curasan AG |
Germany |
| Schleper, Christa (ZEB 200110 Head) |
n. a. |
Zentrum für molekulare Evolution und Biodiversität (ZEB) |
Germany |
| Schlesinger, Monika (TVM Capital Life Science + Healthcare 201507 Global Communications Manager) |
Public Relations Manager / Investor Relations Manager |
TVM (Group) |
Germany |
| Schlichthaar, Rainer (KeyNeurotek 200409– before DrugConsult.NET) |
n. a. |
KeyNeurotek (Group) |
Germany |
| Schlichting, Mathias P. (Brehm & v Moers Attorneys 201101 Attorney + Partner) |
Attorney / Lawyer |
Brehm & v. Moers Rechtsanwälte und Steuerberater Partnerschaftsgesellschaft |
Germany |
| Schlick, Erich (Wellington Partners 201009 before 3i Healthcare Deutschland 200403) |
Investment Manager |
Wellington Partners (Group) |
Germany |
| Schliephack, Hinrich (GlycoUniverse 201310 Managing Director + Co-founder) |
Managing Director |
GlycoUniverse (Group) |
Germany |
| Schlieter, Axel (Dentons 202005 Partner at Düsseldorf Office) |
Attorney / Lawyer |
Dentons (Group) |
Germany |
| Schlingensiepen, Karl-Hermann (Antisense Pharma 201107 Supervisory Board member + consultant before Managing Director) |
Supervisory Board Member |
Isarna Therapeutics GmbH |
Germany |
| Schlingensiepen, Reimar (AudioCure Pharma 201508–COO before Jado 2010– CEO consultant + Antisense Pharma COO/CFO) |
Chief Operating Officer (COO) |
AudioCure Pharma GmbH |
Germany |
| Schlitzer, Guido (High-Tech Gründerfonds 202006– CEO before CFO joined 2005 before tbg + IonGate Biosciences) |
Chief Financial Officer (CFO) |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Schlossmacher, Julian (Eurofins 202004 Head of Marketing + Communications Europe at Eurofins Genomics) |
Sales Manager / Marketing Manager |
Eurofins (Group) |
Germany |
| Schlotterbeck, David (Aperio 201208 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Schlumberger, Wolfgang (PerkinElmer 202105 CEO of Euroimmun) |
Chief Executive Officer (CEO) |
PerkinElmer (Group) |
Germany |
| Schlüter, Anne (CCS Cell Culture Service 200801– Head Molecular Biology) |
n. a. |
Evotec (Group) |
Germany |
| Schlüter, Hartmut (Univ Hamburg 201306 Professor at UKE) |
Professor |
University of Hamburg |
Germany |
| Schlüter, Oliver (Novaliq GmbH 201610 Managing Director (CFO)) |
Chief Financial Officer (CFO) |
HOPP Group (family of Dietmar Hopp) |
Germany |
| Schläpfer, Rolf (Roche 199701–200812 Head of Corporate Communication) |
n. a. |
Roche (Group) |
Switzerland |
| Schlösser, Beate (Endress+Hauser 201705 Assitant Public + Internal Communication) |
Public Relations Manager / Investor Relations Manager |
Endress+Hauser (Group) |
Switzerland |
| Schmalbein, Dieter (Bruker Corp 200809 Managing Director of Bruker BioSpin GmbH) |
Managing Director |
Bruker (Group) |
Germany |
| Schmaus, Gerhard (Symrise 201905 Head of Global Innovation Cosmetic Ingredients Division) |
President/Director/Head Business Group/Unit/Division |
Symrise (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 62 63 64 ... 81 82 83 
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
